Cargando…
Impact of COVID-19 Confinement on Quality of Life of Patients with Age-Related Macular Degeneration: A Two-Wave Panel Study
Age-related macular degeneration (AMD) is the leading cause of blindness in developed countries. Intravitreal injections of antiangiogenic agents (anti-VEGF) can stop vision loss in the neovascular form of the disease (nAMD). The aim of this study was to assess the general health-related quality of...
Autores principales: | Sanabria, María R., Calles-Monar, Paola S., Alonso-Tarancón, Ana M., Coco-Martín, Rosa M., Mayo-Iscar, Agustín |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058256/ https://www.ncbi.nlm.nih.gov/pubmed/36983394 http://dx.doi.org/10.3390/jcm12062394 |
Ejemplares similares
-
Quality of Life in Women over 65 Years of Age Diagnosed with Osteoporosis
por: Pastor-Robles, María Belén, et al.
Publicado: (2022) -
Predictive models of long-term anatomic outcome in age-related macular degeneration treated with as-needed Ranibizumab
por: Gonzalez-Buendia, Lucia, et al.
Publicado: (2017) -
Management of significant reactivation of old disciform scars in wet Age-Related Macular Degeneration
por: Coco, Rosa M, et al.
Publicado: (2014) -
Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD)
por: García-Onrubia, Luis, et al.
Publicado: (2020) -
Funduscopic results after 4-year follow-up treatment with ranibizumab for age-related macular degeneration in a region of Spain
por: Coco, Rosa M, et al.
Publicado: (2014)